SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001062993-20-005594
Filing Date
2020-11-13
Accepted
2020-11-12 19:36:59
Documents
12
Period of Report
2020-12-08

Document Format Files

Seq Description Document Type Size
1 FORM 6-K form6k.htm 6-K 6323
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 434050
3 EXHIBIT 99.2 exhibit99-2.htm EX-99.2 854
4 EXHIBIT 99.3 exhibit99-3.htm EX-99.3 637
5 EXHIBIT 99.4 exhibit99-4.htm EX-99.4 931
6 GRAPHIC exhibit99-1x001.jpg GRAPHIC 6328
7 GRAPHIC exhibit99-1x002.jpg GRAPHIC 4054
8 GRAPHIC exhibit99-2xu001.jpg GRAPHIC 107875
9 GRAPHIC exhibit99-2xu002.jpg GRAPHIC 95905
10 GRAPHIC exhibit99-3xu001.jpg GRAPHIC 76284
11 GRAPHIC exhibit99-4xu001.jpg GRAPHIC 130579
12 GRAPHIC exhibit99-4xu002.jpg GRAPHIC 89290
  Complete submission text file 0001062993-20-005594.txt   1147992
Mailing Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1
Business Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1 604-248-8693
REPLICEL LIFE SCIENCES INC. (Filer) CIK: 0001205059 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-50112 | Film No.: 201308671
SIC: 1040 Gold and Silver Ores
Office of Energy & Transportation